Stockscreener 앱 받기
74.32
1.11%
-0.83
전일 마감가:
$75.15
열려 있는:
$74.81
하루 거래량:
7.55M
Relative Volume:
0.57
시가총액:
$110.30B
수익:
$20.08B
순이익/손실:
$2.89B
주가수익비율:
38.33
EPS:
1.9391
순현금흐름:
$3.66B
1주 성능:
-2.57%
1개월 성능:
-19.67%
6개월 성능:
-29.30%
1년 성능:
-26.21%
1일 변동 폭
$74.08
$74.91
1주일 범위
$73.81
$76.87
52주 변동 폭
$72.69
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
74.33 | 111.51B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
114.83 | 199.24B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
384.11 | 145.93B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.92 | 124.03B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
EW
Edwards Lifesciences Corp
|
83.65 | 47.82B | 6.07B | 1.06B | 799.60M | 1.8527 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Finviz
Boston Scientific Adds Starbucks And Takeda Leaders To Guide Capital And Growth - Yahoo Finance
Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree - The Business Journals
Boston Scientific adds Starbucks CFO and biopharma giant CEO to board - Worcester Business Journal
Boston Scientific (BSX) Expands Board and Increases Stock Repurc - GuruFocus
Boston Scientific (BSX) Increases Stock Buyback Program by $4 Bi - GuruFocus
Boston Scientific (BSX) expands board, approves $5.0B share repurchase plan - Stock Titan
Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds - Insider Monkey
Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight - GlobeNewswire Inc.
Former Boston Scientific Executive Joins Ceryx Medical’s Board - Medical Product Outsourcing
Penumbra earnings on deck as Boston Scientific deal looms By Investing.com - Investing.com South Africa
Penumbra earnings on deck as Boston Scientific deal looms - Investing.com
Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors - Finviz
Boston Scientific adds two directors to board - Investing.com
Starbucks CFO, Takeda CEO join Boston Scientific board - Stock Titan
Boston ScientificBuying The Dip In This Compounder (NYSE:BSX) - Seeking Alpha
Why Boston Scientific Stock Plummeted Today - AOL.com
Tredje AP fonden Has $104.53 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
King Luther Capital Management Corp Grows Stake in Boston Scientific Corporation $BSX - MarketBeat
Fiera Capital Corp Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Stock is Down 20% This Year. Here Is What Investors Need to Know Before March 28 - TIKR.com
BSX vs. ABT: Which MedTech Stock is the Better Investment Now? - Finviz
Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific CorporationBSX - PR Newswire
Ontario Teachers Pension Plan Board Takes $20 Million Position in Boston Scientific Corporation $BSX - MarketBeat
L & S Advisors Inc Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific: BUY on WATCHMAN Growth Optionality and Favorable CHAMPION-AF Risk/Reward Setup - TipRanks
Boston Scientific Can't Void Rival's Heart Valve Patent - Law360
May Hill Capital LLC Sells 24,240 Shares of Boston Scientific Corporation $BSX - MarketBeat
NEOS Investment Management LLC Buys 58,819 Shares of Boston Scientific Corporation $BSX - MarketBeat
How Investors May Respond To Boston Scientific (BSX) EP Momentum And CHAMPION‑AF Data Overhang - Yahoo! Finance Canada
Boston Scientific Corporation (NYSE:BSX) Short Interest Update - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Buys Boston Scientific Corporation (NYSE:BSX) Shares - MarketBeat
GSA Capital Partners LLP Has $1.86 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Skandinaviska Enskilda Banken AB publ Buys 529,529 Shares of Boston Scientific Corporation $BSX - MarketBeat
M&G PLC Increases Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Peering Into Boston Scientific Corp's Recent Short Interest - Benzinga
Vanguard Group Inc. Buys 1,115,337 Shares of Boston Scientific Corporation $BSX - MarketBeat
Capital Planning Advisors LLC Invests $1.45 Million in Boston Scientific Corporation $BSX - MarketBeat
Assetmark Inc. Sells 82,501 Shares of Boston Scientific Corporation $BSX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
State of New Jersey Common Pension Fund D Purchases 21,386 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (BSX) Maintains Analyst Ratings Amid Target Adjustments - Finviz
Aberdeen Group plc Has $257.62 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
ABN Amro Investment Solutions Has $54.76 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Stock Slide Tests Support As Outlook And Value Diverge - Yahoo Finance
Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price - Yahoo Finance
Can Boston Scientific Corporation stock sustain margin levelsIPO Watch & Risk Controlled Daily Trade Plans - mfd.ru
Does Boston Scientific Corporation stock benefit from AI growthWeekly Trade Analysis & Fast Entry Momentum Trade Alerts - mfd.ru
Atria Investments Inc Purchases 35,788 Shares of Boston Scientific Corporation $BSX - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.11%
자본화:
|
볼륨(24시간):